Manish Bansal
Overview
Explore the profile of Manish Bansal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
198
Citations
1705
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wasir A, Bansal M, Jaiswal A, Pande S, Thakur A, Sarin H, et al.
Heart Views
. 2025 Mar;
25(3):187-192.
PMID: 40028243
Left ventricular (LV) regional wall motion abnormalities are common in cardiac sarcoidosis but coronary occlusion is very rare. Here, we report a case of cardiac sarcoidosis with very unusual coronary...
2.
Kalustian A, Hagan J, Brlecic P, Iacobas I, Vanderlaan R, Burns J, et al.
JACC Adv
. 2025 Jan;
3(12):101401.
PMID: 39817060
Background: Early clinical outcomes data for adjunctive systemic sirolimus therapy (SST) for moderate to severe pediatric pulmonary vein stenosis (PVS) are promising but limited. Objectives: The authors aimed to characterize...
3.
Bansal M, Kasliwal R, Chandra P, Kapoor R, Chouhan N, Bhan A, et al.
Diabetes Metab Syndr
. 2024 Dec;
19(1):103183.
PMID: 39733493
Background: The atherogenic potential of remnant cholesterol, which refers to the cholesterol content of triglyceride-rich, non-low-density lipoprotein (LDL) particles in circulation, has gained increasing attention recently. Unfortunately, very limited information...
4.
Bansal M, Kasliwal R, Chandra P, Kapoor R, Chouhan N, Bhan A, et al.
Indian Heart J
. 2024 Nov;
76(6):414-417.
PMID: 39571932
This study aimed to assess the effectiveness of current lipid-lowering therapy in achieving low-density lipoprotein cholesterol (LDL-C) goals in Indian patients undergoing coronary revascularization. Consecutive subjects (n = 1275, mean...
5.
Grewal H, Jain M, Bhat R, Nandwani A, Yadav D, Bansal S, et al.
Acta Cardiol
. 2024 Nov;
79(10):1094-1100.
PMID: 39545266
Background: Patients with chronic kidney disease (CKD) undergoing maintenance haemodialysis (MHD) develop several abnormalities of left ventricular (LV) structure and function. Speckle-tracking echocardiography permits compressive assessment of LV myocardial deformation....
6.
Puri R, Mehta V, Bansal M, Duell P, Iyengar S, Shetty S, et al.
J Assoc Physicians India
. 2024 Oct;
72(10):71-76.
PMID: 39390866
Adverse cardiovascular (CV) events have declined in Western countries due at least in part to aggressive risk factor control, including dyslipidemia management. The American and European (Western) dyslipidemia treatment guidelines...
7.
Chopra H, Ponde C, Wander G, Nair T, Ray S, Khullar D, et al.
J Assoc Physicians India
. 2024 Sep;
72(9):75-82.
PMID: 39291524
The incidence of heart failure (HF) in India is estimated to be 0.5-1.7 cases per 1,000 people per year, and approximately 4,92,000-1.8 million new cases are detected every year. Despite...
8.
Eilers L, Bansal M, Khan A, Webb M, Qureshi A, Gowda S, et al.
Cardiol Young
. 2024 Sep;
34(10):2142-2145.
PMID: 39269230
Background: Hepatic and splenic venous access are specialised techniques used to perform diagnostic and interventional procedures in the cardiac catheterisation laboratory. Bleeding events are the most commonly reported complication following...
9.
Puri R, Mehta V, Bansal M, Shetty S, Yusuf J, Agarwala R, et al.
J Assoc Physicians India
. 2024 Aug;
72(8):80-82.
PMID: 39163073
Effective lipid management is crucial for preventing atherosclerotic cardiovascular disease (ASCVD). The Western lipid guidelines may not apply to Indian subjects because of the vast differences in cardiovascular (CV) disease...
10.
Singh A, Mukati R, Bansal M
Ann Card Anaesth
. 2024 Jul;
27(3):282-284.
PMID: 38963371
No abstract available.